These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 34895842)

  • 1. Using the behavior change wheel to link published deprescribing strategies to identified local primary healthcare needs.
    Bai I; Isenor JE; Reeve E; Whelan AM; Martin-Misener R; Burgess S; Kennie-Kaulbach N
    Res Social Adm Pharm; 2022 Aug; 18(8):3350-3357. PubMed ID: 34895842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deprescribing interventions in primary health care mapped to the Behaviour Change Wheel: A scoping review.
    Isenor JE; Bai I; Cormier R; Helwig M; Reeve E; Whelan AM; Burgess S; Martin-Misener R; Kennie-Kaulbach N
    Res Social Adm Pharm; 2021 Jul; 17(7):1229-1241. PubMed ID: 32978088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influencers on deprescribing practice of primary healthcare providers in Nova Scotia: An examination using behavior change frameworks.
    Kennie-Kaulbach N; Cormier R; Kits O; Reeve E; Whelan AM; Martin-Misener R; Burge F; Burgess S; Isenor JE
    Med Access Point Care; 2020; 4():2399202620922507. PubMed ID: 36204093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers and enablers for deprescribing benzodiazepine receptor agonists in older adults: a systematic review of qualitative and quantitative studies using the theoretical domains framework.
    Evrard P; Pétein C; Beuscart JB; Spinewine A
    Implement Sci; 2022 Jul; 17(1):41. PubMed ID: 35804428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying barriers and facilitators to deprescribing benzodiazepines and sedative hypnotics in the hospital setting using the Theoretical Domains Framework and the Capability, Opportunity, Motivation and Behaviour (COM-B) Model: a qualitative study.
    Keller MS; Carrascoza-Bolanos J; Breda K; Kim LY; Kennelty KA; Leang DW; Murry LT; Nuckols TK; Schnipper JL; Pevnick JM
    BMJ Open; 2023 Feb; 13(2):e066234. PubMed ID: 36813499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a hospital deprescribing implementation framework: A focus group study with geriatricians and pharmacists.
    Scott S; Twigg MJ; Clark A; Farrow C; May H; Patel M; Taylor J; Wright DJ; Bhattacharya D
    Age Ageing; 2019 Dec; 49(1):102-110. PubMed ID: 31711097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers and enablers to deprescribing for older people in care homes: The theory-based perspectives of pharmacist independent prescribers.
    Alharthi M; Wright D; Scott S; Birt L
    Res Social Adm Pharm; 2023 May; 19(5):746-752. PubMed ID: 36732210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare professionals' perspectives of deprescribing in older patients at the end of life in hospice care: a qualitative study using the Theoretical Domains Framework.
    Alwidyan T; McCorry NK; Parsons C
    Int J Pharm Pract; 2023 May; 31(3):305-313. PubMed ID: 36866441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breaking barriers: using the behavior change wheel to develop a tailored intervention to overcome workplace inhibitors to breaking up sitting time.
    Ojo SO; Bailey DP; Brierley ML; Hewson DJ; Chater AM
    BMC Public Health; 2019 Aug; 19(1):1126. PubMed ID: 31420033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing the prescribing behaviour of independent prescriber optometrists: a qualitative study using the Theoretical Domains Framework.
    Spillane D; Courtenay M; Chater A; Family H; Whitaker A; Acton JH
    Ophthalmic Physiol Opt; 2021 Mar; 41(2):301-315. PubMed ID: 33608897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persons With Diabetes and General/Family Practitioner Perspectives Related to Therapeutic Inertia in Type 2 Diabetes Mellitus Using Qualitative Focus Groups and the Theoretical Domains Framework: Results From the MOTION Study.
    Wrzal PK; Mohseni AA; Fournier C; Goldenberg R; Hollahan D; Jin S; Pedersen SD; Vallis M; Bunko A; Myageri V; Kukaswadia A; Neish CS; Ivers NM
    Can J Diabetes; 2022 Mar; 46(2):171-180. PubMed ID: 35288041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidisciplinary DEprescribing review for Frail oldER adults in long-term care (DEFERAL): Implementation strategy design using behaviour science tools and stakeholder engagement.
    Heinrich CH; McHugh S; McCarthy S; Curran GM; Donovan MD
    Res Social Adm Pharm; 2023 Aug; 19(8):1202-1213. PubMed ID: 37230873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facilitators and Barriers Influencing Antipsychotic Medication Prescribing and Deprescribing Practices in Critically Ill Adult Patients: a Qualitative Study.
    Jaworska N; Krewulak KD; Schalm E; Niven DJ; Ismail Z; Burry LD; Leigh JP; Fiest KM
    J Gen Intern Med; 2023 Aug; 38(10):2262-2271. PubMed ID: 37072535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A qualitative study to investigate community pharmacists' perceptions about identifying and addressing inappropriately prescribed analgesia.
    Meaadi J; Obara I; Nazar H
    Int J Pharm Pract; 2023 Jun; 31(4):396-402. PubMed ID: 37067949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Professional roles of general practitioners, community pharmacists and specialist providers in collaborative medication deprescribing - a qualitative study.
    Gerlach N; Michiels-Corsten M; Viniol A; Schleef T; Junius-Walker U; Krause O; Donner-Banzhoff N
    BMC Fam Pract; 2020 Sep; 21(1):183. PubMed ID: 32887551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General practitioner views on the determinants of test ordering: a theory-based qualitative approach to the development of an intervention to improve immunoglobulin requests in primary care.
    Cadogan SL; McHugh SM; Bradley CP; Browne JP; Cahill MR
    Implement Sci; 2016 Jul; 11(1):102. PubMed ID: 27435839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring deprescribing opportunities for community pharmacists using the Behaviour Change Wheel.
    Korenvain C; MacKeigan LD; Dainty KN; Guilcher SJT; McCarthy LM
    Res Social Adm Pharm; 2020 Dec; 16(12):1746-1753. PubMed ID: 32094042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimising antimicrobial stewardship interventions in English primary care: a behavioural analysis of qualitative and intervention studies.
    Borek AJ; Wanat M; Atkins L; Sallis A; Ashiru-Oredope D; Beech E; Butler CC; Chadborn T; Hopkins S; Jones L; McNulty CAM; Roberts N; Shaw K; Taborn E; Tonkin-Crine S
    BMJ Open; 2020 Dec; 10(12):e039284. PubMed ID: 33334829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-design of a behaviour change intervention to equip geriatricians and pharmacists to proactively deprescribe medicines that are no longer needed or are risky to continue in hospital.
    Scott S; Atkins B; Kellar I; Taylor J; Keevil V; Alldred DP; Murphy K; Patel M; Witham MD; Wright D; Bhattacharya D
    Res Social Adm Pharm; 2023 May; 19(5):707-716. PubMed ID: 36841632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers and enablers to monitoring and deprescribing opioid analgesics for chronic non-cancer pain: a systematic review with qualitative evidence synthesis using the Theoretical Domains Framework.
    Cross AJ; Buchbinder R; Mathieson S; Bourne A; Maher CG; Lin CC; O'Connor DA
    BMJ Qual Saf; 2022 May; 31(5):387-400. PubMed ID: 35064054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.